Palo Alto Investors LP Long-Term Concentrated

Location: Palo Alto, CA

CIK: 0001306923 · Show all filings

Period: Q4 2021 (← Previous) (Next →)

Filing Date: Feb 14, 2022

Total Value: $1.565B (100.0% shares, 0.0% debt)

Holdings (37)

BMRN BIOMARIN PHARMACEUTICAL INC 12.5%
Value $196M Shares 2,212,950 Est. Cost $83.16 Unrealized -0.8%
ABIOMED INC 11.9%
Value $186M Shares 519,033 Est. Cost $81.43 Unrealized
INSM INSMED INC 10.5%
Value $164M Shares 6,025,706 Est. Cost $17.79 Unrealized +60.7%
UTHR UNITED THERAPEUTICS CORP 9.5%
Value $148M Shares 687,206 Est. Cost $89.23 Unrealized +120.0%
FOLD AMICUS THERAPEUTICS INC 7.5%
Value $117M Shares 10,114,043 Est. Cost $9.52 Unrealized +17.1%
STAA STAAR SURGICAL CO 6.7%
Value $104M Shares 1,140,511 Est. Cost $14.28 Unrealized +651.5%
BIIB BIOGEN INC 5.9%
Value $92.37M Shares 385,000 Est. Cost $264.06 Unrealized -2.6%
PRTA PROTHENA CORP PLC 5.3%
Value $83.25M Shares 1,685,282 Est. Cost $21.46 Unrealized +158.4%
REVANCE THERAPEUTICS INC 4.6%
Value $71.31M Shares 4,369,366 Est. Cost $22.01 Unrealized
ACAD ACADIA PHARMACEUTICALS INC 3.5%
Value $54.57M Shares 2,337,877 Est. Cost $33.89 Unrealized -40.7%
VNDA VANDA PHARMACEUTICALS INC 2.8%
Value $44.47M Shares 2,834,244 Est. Cost $11.21 Unrealized +55.4%
EHTH EHEALTH INC 2.6%
Value $41.2M Shares 1,615,570 Est. Cost $60.36 Unrealized -45.0%
ALGN ALIGN TECHNOLOGY INC 2.3%
Value $36.41M Shares 55,405 Est. Cost $114.31 Unrealized +462.4%
KARYOPHARM THERAPEUTICS INC 2.2%
Value $35.17M Shares 5,470,452 Est. Cost $16.61 Unrealized
SAGE THERAPEUTICS INC 2.1%
Value $33.26M Shares 781,730 Est. Cost $47.83 Unrealized
GRITSTONE ONCOLOGY INC 1.9%
Value $30.3M Shares 2,356,282 Est. Cost $9.42 Unrealized
GOSS GOSSAMER BIO INC 1.3%
Value $20.05M Shares 1,772,950 Est. Cost $11.85 Unrealized +0.3%
ALKS ALKERMES PLC 1.1%
Value $17.54M Shares 754,200 Est. Cost $22.36 Unrealized +17.6%
ANAB ANAPTYSBIO INC 1.0%
Value $15.17M Shares 436,592 Est. Cost $19.06 Unrealized +66.4%
EPIZYME INC 0.9%
Value $13.71M Shares 5,485,213 Est. Cost $14.39 Unrealized
SNDX SYNDAX PHARMACEUTICALS INC 0.8%
Value $13.11M Shares 598,900 Est. Cost $16.84 Unrealized +9.7%
KEZAR LIFE SCIENCES INC 0.7%
Value $10.97M Shares 656,200 Est. Cost $5.16 Unrealized
CLOVIS ONCOLOGY INC 0.7%
Value $10.83M Shares 3,997,826 Est. Cost $47.56 Unrealized
CYTK CYTOKINETICS INC 0.4%
Value $5.638M Shares 123,686 Est. Cost $6.71 Unrealized +474.8%
TVTX TRAVERE THERAPEUTICS INC 0.3%
Value $5.155M Shares 166,069 Est. Cost $23.56 Unrealized +19.6%
ZOGENIX INC 0.2%
Value $2.987M Shares 183,800 Est. Cost $20.95 Unrealized
MAGENTA THERAPEUTICS INC 0.1%
Value $1.915M Shares 432,300 Est. Cost $7.38 Unrealized
NVAX NOVAVAX INC 0.1%
Value $1.788M Shares 12,500 Est. Cost $171.82 Unrealized 0.0%
RIGEL PHARMACEUTICALS INC 0.1%
Value $1.729M Shares 652,395 Est. Cost $3.40 Unrealized
AZN ASTRAZENECA PLC-SPONS ADR 0.1%
Value $1.704M Shares 29,260 Est. Cost $60.06 Unrealized
MIRM MIRUM PHARMACEUTICALS INC 0.1%
Value $1.032M Shares 64,700 Est. Cost $15.56 Unrealized 0.0%
ALIMERA SCIENCES INC 0.1%
Value $1.031M Shares 200,919 Est. Cost $6.30 Unrealized
KLDO KALEIDO BIOSCIENCES INC 0.1%
Value $815K Shares 341,030 Est. Cost $13.76 Unrealized -70.4%
ALDX ALDEYRA THERAPEUTICS INC 0.0%
Value $643K Shares 160,800 Est. Cost $7.10 Unrealized +7.5%
TCMD TACTILE SYSTEMS TECHNOLOGY I 0.0%
Value $516K Shares 27,100 Est. Cost $39.74 Unrealized -28.6%
MARINUS PHARMACEUTICALS INC 0.0%
Value $372K Shares 31,330 Est. Cost $15.48 Unrealized
URGN UROGEN PHARMA LTD 0.0%
Value $233K Shares 24,500 Est. Cost $27.01 Unrealized -47.8%